Myopia, Progressive Clinical Trial
Official title:
A Prospective Clinical Trial on Slow Myopia Progression With Two Different Irradiance Light at Baseline and Dynamic Changes at Follow-up
It is a prospective clinical control study on red light control myopia with specail design spectacles for 75 children in 3 groups. Study Groups with two different powers of 0.6 mW and 1.2 mW at wavelength of 650nm. The control group is to wear the same brand and design spectalces as those two study groups. In addition, the progression of myopia is usually accompanied by the changes in a variety of ocular parameters, such as refractive error, reduced submacular choroidal thickness, and prolonged length of the ocular axis length.The goal is to test which power (1.2mW and 0.6mW) is better in myopic children for 3 month's follow-up and also to test how to get better result with the increaing or decreasing lighting power for the total 6 month follow-up results .
It is a prospective clinical control study on red light control myopia with specail design spectacles for 75 children in 3 groups. Each group has 25 myopic children. Study Groups with two different powers of 0.6 mW and 1.2 mW at wavelength of 650nm are randomized to be allocated into the 3 groups. The control group is to wear the same brand and design spectalces as those two study groups. In addition, the progression of myopia is usually accompanied by the changes in a variety of ocular parameters, such as refractive error, reduced submacular choroidal thickness, and prolonged length of the ocular axis length. All groups will be wearing a special lens named by Stellest with high aspherical lens design. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05919654 -
Clinical Evaluation of MyoCare in Europe (CEME)
|
N/A | |
Recruiting |
NCT03402100 -
Eye Drops Study for Myopia Control in Schoolchildren
|
N/A | |
Recruiting |
NCT03865160 -
Low-dose Atropine for Myopia Control in Children
|
Phase 2/Phase 3 | |
Recruiting |
NCT06088225 -
Myopia Preventing With Distance-image Screen
|
N/A | |
Not yet recruiting |
NCT06085430 -
Kubota Glass Parameter Refinement Study
|
N/A | |
Not yet recruiting |
NCT06405711 -
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
|
N/A | |
Recruiting |
NCT05761379 -
Clinical Study of Light Therapy to Control Myopia Progression in Children
|
N/A | |
Not yet recruiting |
NCT05760911 -
Myopia Prevention Through Monitoring and Motivating Outdoor Activities With Smartwatches
|
N/A | |
Recruiting |
NCT04722874 -
Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control
|
N/A | |
Not yet recruiting |
NCT06221592 -
Differences and Wearing Safety and Comfort of New Defocus Incorporated Multiple Segments Spectacle Lenses
|
N/A | |
Completed |
NCT04806698 -
Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia
|
N/A | |
Completed |
NCT04806763 -
Myopia Control With Orthokeratology Contact Lenses in Spain
|
N/A | |
Completed |
NCT04806711 -
Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children
|
N/A | |
Recruiting |
NCT05894382 -
Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control
|
N/A | |
Completed |
NCT05683535 -
Adverse Events Related to Low Dose Atropine
|
||
Completed |
NCT05300321 -
DIMS-myopia Progression ADN Axial Length Growth
|
N/A | |
Withdrawn |
NCT03519490 -
Can Distance Center and Near Center Multifocal Contact Lenses Control Myopia Progression in Children?
|
N/A | |
Completed |
NCT05372991 -
Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05373693 -
Myopia-control Efficacy by Peripheral Defocus Lens (PDL)
|
N/A | |
Completed |
NCT05007626 -
Near Horizontal Heterophoria in Chinese Children
|